Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2024 NCCN Annual Conference
European Association of Urology Congress 2024
AACR Annual Meeting 2024
2024 Miami Breast Cancer Conference
2024 Society of Surgical Oncology Annual Meeting
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
2012 MASCC/ISOO
«
1
»
Advertisement
Advertisement
Apr
26
Today In Oncology
Adjuvant Pembrolizumab in Renal Cell Carcinoma: Overall Survival in KEYNOTE-564
Combined ICI and VEGF Inhibitor Trials in Cancer Cardiovascular Eligibility Criteria and Adverse Event Reporting
Risk of T-Cell and Second Primary Malignant Neoplasms After CAR T-Cell Therapy
Lack of Research Focused on Older Adults With Cancer May Be Contributing to Disparities in Care
Breast Cancer Survivors: Relationship Satisfaction and Emotional and Physical Well-Being
View More
Advertisement
